Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-resistant Epilepsy”

374 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 374 results

Not applicableNot Yet RecruitingNCT07434986
What this trial is testing

Overnight TI in TLE

Who this might be right for
Temporal Lobe Epilepsy (TLE)Drug Resistant EpilepsySleep
Duke University 20
Post-approval studies (Phase 4)UnknownNCT00647322
What this trial is testing

The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy

Who this might be right for
Intractable Epilepsy
Institute of Child Health 64
Not applicableStudy completedNCT03403907
What this trial is testing

The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients

Who this might be right for
EpilepsyEpilepsy Intractable
María Gómez Eguílaz 45
Not applicableStudy completedNCT03860298
What this trial is testing

Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy

Who this might be right for
Drug Resistant EpilepsyEpilepsy, Drug ResistantDrug Refractory Epilepsy+5 more
NaviFUS Corporation 6
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT02495844
What this trial is testing

UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma S.P.R.L. 55
Large-scale testing (Phase 3)WithdrawnNCT02318563
What this trial is testing

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

Who this might be right for
Dravet Syndrome
INSYS Therapeutics Inc
Not applicableStudy completedNCT03105700
What this trial is testing

Low Frequency TMS for Depression in Epilepsy

Who this might be right for
EpilepsyDepressions, Refractory
Dartmouth-Hitchcock Medical Center 15
Not applicableActive Not RecruitingNCT06340802
What this trial is testing

A First in hUman Study for Resistant Epilepsy With the Vagus Nerve stimulatiOn Device by syneRgia medicAl

Who this might be right for
Drug Resistant Epilepsy
Synergia Medical 10
Not applicableUnknownNCT04569071
What this trial is testing

Clinical Trial of MgLiTT for Medical Refractory Epilepsy

Who this might be right for
Epilepsy
Beijing Tiantan Hospital 110
Not applicableNot Yet RecruitingNCT07305311
What this trial is testing

Characterising the Network-Specific Effects of Piriform Cortex Stimulation Via SEEG

Who this might be right for
Refractory EpilepsyNeuromodulation
Xuanwu Hospital, Beijing 10
Not applicableStudy completedNCT04687904
What this trial is testing

Mindfulness Meditation for Epilepsy

Who this might be right for
EpilepsyHealthy Subjects
Rennes University Hospital 37
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Not applicableStudy completedNCT02304029
What this trial is testing

Usefulness of Sodium MRI in the Presurgical Assessment of Drug-resistant Partial Epilepsy

Who this might be right for
Epileptic Seizures
Assistance Publique Hopitaux De Marseille 78
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Not applicableLooking for participantsNCT06524479
What this trial is testing

Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG

Who this might be right for
Refractory EpilepsySleep
Xuanwu Hospital, Beijing 20
Not applicableUnknownNCT04610268
What this trial is testing

Mechanism Study of tDCS on Human Electrophysiological Network Via SEEG

Who this might be right for
Depression
Second Affiliated Hospital, School of Medicine, Zhejiang University 4
Large-scale testing (Phase 3)Ended earlyNCT00524134
What this trial is testing

P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.

Who this might be right for
Epilepsy
Columbia University 6
Not applicableStudy completedNCT06447675
What this trial is testing

Efficacy and Safety Evaluation of Hyperthermic Baths in the Treatment of Seizures in CDKL5 Deficiency Disorder

Who this might be right for
CDKL5 Deficiency Disorder
Xuanwu Hospital, Beijing 8
Early research (Phase 1)Not Yet RecruitingNCT07572812
What this trial is testing

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Who this might be right for
Epilepsy
Shanghai UniXell Biotechnology Co., Ltd 12
Load More Results